Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) Debt to Equity (2016 - 2023)

Aethlon Medical filings provide 13 years of Debt to Equity readings, the most recent being $0.01 for Q1 2023.

  • On a quarterly basis, Debt to Equity rose 55.15% to $0.01 in Q1 2023 year-over-year; TTM through Mar 2023 was $0.01, a 55.15% increase, with the full-year FY2023 number at $0.01, up 55.15% from a year prior.
  • Debt to Equity hit $0.01 in Q1 2023 for Aethlon Medical, up from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $4.91 in Q3 2019 to a low of $0.0 in Q2 2021.
  • Median Debt to Equity over the past 5 years was $0.01 (2020), compared with a mean of $0.31.
  • Biggest five-year swings in Debt to Equity: skyrocketed 19815.5% in 2019 and later tumbled 99.76% in 2020.
  • Aethlon Medical's Debt to Equity stood at $0.03 in 2019, then crashed by 60.59% to $0.01 in 2020, then plummeted by 44.96% to $0.01 in 2021, then soared by 73.76% to $0.01 in 2022, then rose by 29.06% to $0.01 in 2023.
  • The last three reported values for Debt to Equity were $0.01 (Q1 2023), $0.01 (Q4 2022), and $0.01 (Q3 2022) per Business Quant data.